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Article focus
  We aimed to investigate the migration of 
MSCs from young, adult and ovariecto-
mised (ovX) rats and to enhance this migra-
tion by increasing the chemokine receptor 
type 4 (CXCR4) expression of these cells.
Key messages
  CXCR4 improves migration of young, 
adult and ovX Mesenchymal stem cells 
(MSCs).
  The migration of adult/old and osteopae-
nic MSCs may be impaired due to 
reduced levels of CXCR4.
Strengths and limitations
  Strengths: This study is the first to assess 
the CXCR4 expression of MSCs from 
three different groups of rats: young, 
adult and osteopaenic.
  limitation: This was an in vitro study and 
further work needs to be done in vivo to 
establish a clear role of CXCR4 in cell 
migration.
Introduction
Bone fractures in the elderly caused by osteo-
porosis lead to loss of mobility, chronic pain 
and high cost to the individual and society.1 
osteoporosis and ageing affects the 
migration of stem cells and this is 
ameliorated by transfection with cXcR4
Objectives
cellular movement and relocalisation are important for many physiologic properties. Local 
mesenchymal stem cells (Mscs) from injured tissues and circulating Mscs aid in fracture 
healing. cytokines and chemokines such as stromal cell-derived factor 1(sDF-1) and its 
receptor chemokine receptor type 4 (cXcR4) play important roles in maintaining mobili-
sation, trafficking and homing of stem cells from bone marrow to the site of injury. We 
investigated the differences in migration of Mscs from the femurs of young, adult and ovari-
ectomised (oVX) rats and the effect of cXcR4 over-expression on their migration.
Methods
Mscs from young, adult and oVX rats were put in a Boyden chamber to establish their 
migration towards sDF-1. This was compared with Mscs transfected with cXcR4, as well as 
Mscs differentiated to osteoblasts.
Results
Mscs from oVX rats migrate significantly (p < 0.05) less towards sDF-1 (9%, sd 5%) com-
pared with Mscs from adult (15%, sd 3%) and young rats (25%, sd 4%). cells transfected 
with cXcR4 migrated significantly more towards sDF-1 compared with non-transfected 
cells, irrespective of whether these cells were from oVX (26.5%, sd 4%), young (47%, sd 
17%) or adult (21%, sd 4%) rats. Transfected Mscs differentiated to osteoblasts express 
cXcR4 but do not migrate towards sDF-1.
Conclusions
Msc migration is impaired by age and osteoporosis in rats, and this may be associated with 
a significant reduction in bone formation in osteoporotic patients. The migration of stem 
cells can be ameliorated by upregulating cXcR4 levels which could possibly enhance frac-
ture healing in osteoporotic patients.
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The common treatment for osteoporosis is the use of bis-
phosphonates, which increase bone mineral density and 
reduces the risk of osteoporotic fractures. However, its 
long-term use has raised concerns in regard to atypical 
subtrochanteric fractures of the femur.2
Mesenchymal stem cells (MSCs) are multipotent 
stem cells with the ability to self-renew and differentiate 
into various cell lineages. Cellular movement and relo-
calisation are crucial for many important physiologic 
properties such as embryonic development, neovascu-
larisation and angiogenesis, immunologic responses, 
wound healing and organ repair. Both local MSCs from 
the injured tissue and circulating MSCs collaborate in 
the healing of organs during tissue and/or organ regen-
eration. Cytokines and chemokines play important roles 
in maintaining the mobilisation, trafficking and homing 
of stem cells from the bone marrow to the site of injury.3-5 
During tissue regeneration, it has been suggested that 
local MSCs derived from the injured tissue and circulat-
ing MSCs work together in the healing of damaged 
organs. MSCs sense the tissue injury, migrate to the site 
of the damage and undergo differentiation.4,6 This may 
explain the increase of stem cells found in damaged tis-
sues compared with normal healthy tissues such as 
impaired sites in the brain after hypoglossal nerve injury7 
and cerebral injury.8 As a result of injury, the surviving 
cells may produce chemo-attractants such as Stromal 
cell-derived factor 1(SDF-1). With its receptor chemokine 
receptor type 4 (CXCR4), SDF-1 directs the migration of 
MSCs to the injury site.8
Wynn et al9 showed that when a neutralising anti-
CXCR4 antibody was used to block CXCR4 expression, it 
inhibited MSC migration to the bone marrow by approxi-
mately 46%. This study also demonstrated a dose-
dependent migration of MSCs towards SDF-1 in vitro. 
Blocking CXCR4 expression was observed to reduce cell 
migration significantly towards SDF-1.9 lien et al10 trans-
fected murine MSCs with CXCR4 and core-binding factor 
subunit alpha-1 (Cbfa-1) and injected these modified 
cells into osteopaenic mice. A complete recovery of bone 
stiffness and strength in these animals was seen after four 
weeks. A similar study by Cho et al11 also showed that 
over-expression of MSCs with CXCR4 and receptor acti-
vator of NF-kappa B (RANK-Fc) improved bone mineral 
density in ovariectomised mice (ovX), with CXCR4 act-
ing as an important migratory factor and enhancing the 
therapeutic effects of RANK-Fc for bone loss. All of these 
studies highlight the importance of cell migration in bone 
regeneration, however, little information is available on 
the differences in migration capability of MSCs from oste-
opaenic, adult and young rats, and the scope of CXCR4 
in improving the migration of MSCs from these three dif-
ferent groups.
In patients with osteoporosis, there is often an 
increased incidence of delayed union associated with 
fragility fractures. This may be connected to recruitment 
of stem cells to the fracture site and their differentiation to 
bone. Considering the significance of the SDF-1/CXCR4 
axis in homing and engraftment of bone marrow cells 
and the potential of MSCs in bone regeneration therapy, 
we investigated the novel concept of over-expressing 
CXCR4 in stem cells and the way in which this affected 
the migratory capacities of MSCs isolated from young, 
old and ovX rats. We also investigated the effects and 
expression of CXCR4 in osteoblasts differentiated from 
these cells.
Materials and Methods
Cell isolation, cultivation and expansion. MSCs were 
harvested from young two- to four-week-old Wistar 
rats by flushing the femurs with Dulbecco's modified 
eagle medium (DMeM) (Sigma Aldrich, Irvine, united 
Kingdom), 20% foetal calf serum (FCS) (First link ltd, 
Birmingham, united Kingdom) and 1% penicillin strep-
tomycin (Sigma Aldrich). Cells were cultured at 37°C at 
5% Co2. Media were changed after four days to remove 
non-adherent cells. After ten to 14 days of primary cul-
ture, when the cells were 70% to 80% confluent, they 
were passaged using Trypsin-eDTA (Sigma-Aldrich, 
united Kingdom). To characterise the MSCs, passage 3 
(P3) cells were differentiated into osteoblasts, adipocytes 
and chondrocytes by the methods described in the sup-
plementary material and were stained using Alizarin Red 
(Sigma Aldrich), oil Red o (Sigma Aldrich) and Alcian Blue 
(Sigma Aldrich), respectively. For osteogenic differentia-
tion, 30 000 cells were seeded in 48 well plates and the 
media were supplemented with 100 nM dexamethasone 
(Sigma Aldrich), 0.05 mM ascorbic acid (Sigma Aldrich) 
and 10 mM beta-glycerol phosphate (Sigma Aldrich).
Osteopaenic rats. The ovaries from six- to eight-month-
old female Wistar rats (n = 6) were removed and the rats 
were left for four months after surgery before measur-
ing their bone mineral density using peripheral quantita-
tive computed tomography (pQCT) (Stratec XCT 1000; 
Stratec Biomedical Systems, Birkenfeld, Germany) and 
comparing them with non-ovX control rats of the same 
age (n = 6). Cells were obtained from the bone marrow 
of the ovX and control adult rats and cultured as stated 
above.
Preparation of the recombinant adenoviruses. The 
human CXCR4 cDNA (pCMv-Xl5-CXCR4 origene 
Technologies, Inc, Rockville, Maryland) was digested 
by restriction endonucleases NotI and XhoI (Fisher 
Scientific, loughborough, united Kingdom) and then 
inserted into pShuttle-CMv (Adeasy Xl Adenoviral vector 
System; Stratagene, San Diego, California) to form 
pShuttle-CMv-CXCR4. The human CXCR4 gene and the 
pShuttle-CMv vector were both cut by restriction endo-
nucleases NotI and XhoI (Fisher Scientific) and were then 
repaired to form blunt ends. The cuts were confirmed 
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by gel electrophoresis. Human CXCR4 cDNA was then 
cloned into the pShuttle-CMv vector using DNA ligase. 
The presence of the insert was confirmed by restriction 
digest as well as by Sanger sequencing. The incorporated 
shuttle vector was then linearised with PmeI restriction 
endonuclease (Fisher Scientific) and transformed into 
BJ5183-AD-1 competent bacterial cells using electropora-
tion (Fig. 1). A scrambled plasmid was created by insert-
ing no gene into the pShuttle-CMv vector.
Following selection of the smallest colonies, the 
recombinant plasmid was collected using a miniprep kit 
(Thermofisher Scientific, Paisley, united Kingdom) and 
cut using the PacI restriction enzyme (ThermoFisher 
Scientific). The correctly identified copies were then 
largely expanded in bulk using the recombinant-deficient 
Xl10-Gold strain (Adeasy Xl Adenoviral vector System; 
Stratagene, San Diego, California). Purified recombinant 
plasmid DNA, cut with PacI, was then used to transfect 
AD293 cells (Adeasy Xl Adenoviral vector System; 
Stratagene, San Diego, California). The viral particles 
were generated by alternate freezing and thawing of the 
infected AD293 cells and collecting the supernatant. An 
anti-hexon antibody stain, which statins infected cells 
dark brown, was used to determine the plaque-forming 
units/ml (pfu/ml) of the infected cells by counting the 
number of dark infected cells.
Sequencing method. A Polymerase chain reaction (PCR) 
was carried out on 3.5 μl (500 ng) of the purified plas-
mid DNA (pShuttle-CMv-CXCR4) using the Pshuttle CMv 
forward (5’GGTCTATATATAAGCAGAGCTG) and CXCR4 
reverse primer (3’ATGAATGTCCACCTCGCTTT), sequenc-
ing buffer (ABI 4336699) and BigDye v3.1 (ABI 4337455; 
Thermo Fisher Scientific, Waltham, Massachusetts). PCR 
products were then purified using ethanol precipita-
tion and centrifuged at 3000 rpm for 30 minutes. The 
products were then dried and washed with 70% ethanol, 
spun down and resuspended in Hi-Di Formamide (ABI 
4440753), and analysed in a Sanger sequencer. A nega-
tive control with no DNA was also sequenced to validate 
the results.
Analysis of CXCR4 over-expression on infected cells. Young, 
adult and ovX MSCs from the third passage were infected 
with the CXCR4 adenovirus at a Multiplicity of Infection 
(MoI) of 800, and then trypsinised and centrifuged at 
2000 rpm for ten minutes before being resuspended at 
100 000 cells in phosphate-buffered saline (PBS). Cell ali-
quots were permeabilised at -20°C in methanol for ten 
minutes and incubated with primary CXCR4 antibody 
(Abcam, Cambridge, united Kingdom) for one hour at 
room temperature. The cells were washed in PBS and 
then incubated in secondary goat anti-rabbit antibody 
(Abcam, Cambridge, united Kingdom) for 30 minutes 
at room temperature. The negative control consisted of 
cells incubated in the secondary antibody only. Ten thou-
sand cells were then analysed using a flow cytometry 
machine (CytoFleX; Beckman Coulter, High Wycombe, 
united Kingdom). The results were compared with unin-
fected MSCs from the same rats.
Chemoinvasion assay. A chemoinvasion assay was used 
to evaluate the ability of MSCs, CXCR4-infected MSCs, 
scrambled infected MSCs and osteogenic differentiated 
MSCs to migrate towards SDF-1. To confirm osteogenic 
differentiation of MSCs cells were stained with Alizarin Red 
(Sigma Aldrich) and their osteocalcin expression analysed 
using immunocytochemistry after 21 days. A total of 25 
000 osteogenic differentiated rBMCs and undifferentiated 
rBMCs were loaded separately in serum-free medium into 
upper compartments of the Boyden chamber, 5 µm pore 
size (Corning Inc., Corning, New York). The lower com-
partment of the Boyden chamber was filled with 100 ng/
ml SDF-1 (Peprotech eC ltd, london, united Kingdom) 
in DMeM, FCS and penicillin/streptomycin. The chambers 
were incubated at 37°C, 5% Co2, for 16 hours.
After 16 hours, the cells that migrated to the opposite 
side of the membrane were fixed in 10% formaldehyde 
(Sigma Aldrich) and stained with Crystal violet (Sigma 
Aldrich). The migrated cells were counted by selecting six 
random fields at x20 magnification and calculating the 
percentage average number of cells. For each cell type 
CXCR4 gene
pShuttle
vector
PacI linearise
Adenovirus
Backbone 
vector
Fig. 1
A schematic diagram showing the production stages of the recombinant 
adenovirus using the Adeasy Xl Adenoviral vector System (Stratagene, San 
Diego, California).
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(young, adult and ovX) and differentiation state (undif-
ferentiated and osteogenic), the experiment was repeated 
three times. For the control, both the top and bottom of 
the chamber were filled with normal media with no SDF-
1. In a similar but separate study, 10 000 cells transfected 
with CXCR4 and scrambled plasmid at MoI 800, and 
uninfected cells, were introduced into the chamber. The 
migrated cells were stained and counted after 16 hours 
and the data were normalised against uninfected cells.
Statistical analysis. Data were analysed using a Student 
t-test via SPSS Statistics (IBM Corp., Armonk, New York) 
and results were considered significant at the 0.05 level. 
All data has been represented as mean standard deviation.
Results
establishment of the rat osteoporotic model. At four 
months post surgery, the average bone mineral density 
of the ovX rats was 538.2 g/cm3 (sd 23.3) in comparison 
with 666.9 g/cm3 (sd 46) for the sham rats, which was a 
reduction of 24% (sd 9%). Qualitative histomorphometri-
cal results revealed significantly lower bone mass volume 
and thinner trabecular thickness in the ovX group, with a 
larger number of adipocytes occupying the stromal frac-
tion of the bone marrow.
CXCR4 expression and migration of infected and unin-
fected cells. Non-transfected MSCs from younger rats 
expressed significantly greater amounts of CXCR4 
(87.5%, sd 5.1%) in comparison with those isolated 
from adult (28.1%, sd 1.5%) and ovX rats (20.2%, sd 
9.8%)(Fig. 2). osteopaenia did not appear to be a factor 
in CXCR4 expression as the ovX rats expressed similar 
amounts to those of the control adult rats. However, we 
observed that a significantly lower number of MSCs from 
the ovX rats migrated towards SDF-1 compared with the 
adult and young rats. The migration of MSCs obtained 
from young rats was twice that seen in cells from adult 
rats (p = 0.023) and four times that of cells isolated from 
ovX rats (p = 0.013) (Fig. 3). Moreover, the migration of 
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Fig. 2
Flow cytometry showing the chemokine receptor type 4 (CXCR4) expression of mesenchymal stem cells (MSCs) from young, adult control and ovariectomised 
(ovX) rats. The histograms show a comparison between the isotype control (red), CXCR4 expression in uninfected MSCs (green) and the over-expression of 
CXCR4 after transfection with the adenovirus (pink).
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migration of infected cells normalised against uninfected cells. *, ** and *** represent p < 0.05.
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MSCs from young rats was significantly higher in plain 
media (without SDF-1) than those from adult and ovX 
rats.
To enhance migration of MSCs, a human CXCR4 gene 
was introduced into rat MSCs through adenovirus infec-
tion. We tested the effect of CXCR4 transfected cells, 
scrambled plasmid-infected cells and uninfected cells on 
cell migration towards SDF-1 using the transwell migra-
tion assay. The data were normalised to the migration of 
uninfected cells to measure the effect of CXCR4 transfec-
tion on cells isolated from young, adult and ovX animals. 
After transfection with the CXCR4 virus, 92% (sd 2.6%), 
44.2% (sd 8.2%) and 40% (sd 16.1%) of young, adult 
control and ovX MSCs, respectively, over-expressed 
CXCR4. over-expression of CXCR4 significantly increased 
the migration of young MSCs towards SDF-1 by 80% in 
comparison with uninfected cells (p = 0.006). Although 
slightly fewer scrambled infected cells migrated towards 
SDF-1 in comparison with the uninfected cells (p = 0.03), 
there was a significant difference in the migration between 
the infected and scrambled infected cells (p  =  0.003) 
towards SDF-1, demonstrating that over-expression of 
CXCR4 increased cell migration towards this cytokine. It 
was important to note that although the migration of 
young MSCs towards SDF-1 was greatest after CXCR4 
transfection, the effect of CXCR4 was more profound in 
rat MSCs from ovX rats. A five-fold increase in migration 
of MSCs from ovX rats towards SDF-1was seen after 
CXCR4 transfection compared with uninfected ovX cells 
(p = 0.025) (Fig. 3). CXCR4 expression in ovX MSCs was 
doubled, while in young MSCs it only increased by 5% 
after CXCR4 transfection (Table I).
The migration capacity of MSCs decreases after osteogenic 
differentiation. To determine whether osteogenic differ-
entiation of rat MSCs affects migration towards SDF-1 and 
whether transfection with CXCR4 of these cells increases 
their migratory capacity, we repeated the migration assay 
on stem cells grown for 21 days in osteogenic medium. 
Positive differentiation of MSCs to osteoblasts was con-
firmed by osteocalcin staining and Alizarin Red (Sigma 
Aldrich) staining at day 21 (Figs 4b and 4c). CXCR4-
infected cells were also differentiated to osteoblasts 
and differentiation significantly reduced their migration 
towards SDF-1 (6.7%, sd 2.3%) compared with undiffer-
entiated MSCs (23.2 sd 4%) (p = 0.0006). Interestingly, 
we also observed that, when CXCR4-infected MSCs were 
differentiated to osteoblasts, their migration capability 
towards SDF-1 did not significantly improve (11.25%, 
sd 8.6%) whereas transfection significantly improved the 
migration of undifferentiated MSCs (47%, sd 17%) even 
though both sets of cells positively expressed CXCR4 
(Fig. 5).
Discussion
These in vitro studies have highlighted the pivotal role 
that the SDF-1/CXCR4 axis plays in the homing of stem 
cells and the potential significance this may have in 
improving bone formation in osteoporosis. This study 
showed that cells transfected with CXCR4 increased 
migration towards SDF-1 in transwell chambers in com-
parison with uninfected cells. CXCR4 was therefore seen 
to play an essential role in stem cell migration in tran-
swell assays. Due to the ageing process, bone composi-
tion, structure and function deteriorates which results in 
osteoporosis.12 It has also been demonstrated that MSCs 
from osteoporotic humans have impaired migration 
towards chemo-attractants such as foetal calf serum 
(FCS), bone morphogenetic protein (BMP)-2 and BMP-7 
in Boyden chambers, as well as in micro-slide chemotaxis 
chambers.13 SDF-1 has previously been shown to recruit 
more host stem cells to a fracture defect site and to 
encourage osteogenic differentiation and production of 
bone.14
When considering the effect of age on cells, this study 
has also demonstrated that stem cells from ovX and 
adult rats express lower levels of CXCR4 on their surface 
compared with stem cells from young rats, which might 
explain their impaired migration towards SDF-1. These 
results are consistent with those reported by other stud-
ies.15,16 liang et al17 intravenously injected lethally irradi-
ated young or old ly-5.1 mice with old or young ly-5.2 
bone marrow cells. The marrow from the recipients for 
ly-5.2+ stem cells that had homed there was analysed 
after 24 hours. It was found that the older cells migrated 
two to three times less to the bone marrow niche com-
pared with the young cells.17 This was most likely due to 
defective CXCR4 expression during ageing, reducing the 
number of CXCR4-positive cells in the bone marrow and 
in the circulation.16 This significance has been highlighted 
in the present study where the mobility of stem cells from 
ovX rats towards SDF-1 was increased when their CXCR4 
expression was upregulated.
Table I. The percentage chemokine receptor type 4 (CXCR4) expression before and after CXCR4 transfection in young, adult control and ovariectomised (ovX) 
mesenchymal stem cells
Type of cells CXCR4 expression before transfection (%) CXCR4 expression after transfection (%) Percentage increase (%)
Young MSCs 87.5, sd5.1* 92, sd 2.6* 5.1
Adult MSCs 28.1, sd 1.5* 44.2, sd 8.2* 57.2
ovX MSCs 20.2, sd 9.8* 40 sd, 16.1* 97.9
*represents significance p < 0.05.
MSC, mesenchymal stem cell; CXCR4, chemokine receptor type 4.
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SDF-1 causes cell migration by binding with CXCR4, 
and therefore increased secretion of SDF-1 at the site of 
injury creates an environment that mediates the homing 
of circulating CXCR4-positive stem cells. The cells will 
subsequently differentiate into the surrounding tissue 
type and affect repair at the injury site.18 Poor homing 
ability of the stem cells to bone could result in a signifi-
cant reduction in bone formation which ultimately con-
tributes to osteoporosis.19
oestrogen deficiency is the main cause that leads to 
postmenopausal osteoporosis. oestrogen improves oste-
oblastic differentiation of hBMSCs through eR-α20 or acti-
vating Wnt/β-catenin signalling.21 Deficiency in oestrogen 
also affects the circulating levels of cytokines such as 
interleukin (Il)-1, tumour necrosis factor (TNF)-α and 
granulocyte macrophage colony-stimulating factor 
(GM-CSF). Increased levels of these cytokines due to 
reduction in oestrogen enhance bone resorption.22,23 The 
notch signalling pathway has been shown to induce 
osteogenic differentiation and inhibit adipogenic differ-
entiation of BMSCs.24
A study performed by Fan et al25 has shown that 
 oestrogen-upregulated Notch signalling enhanced the 
proliferation and differentiation of hBMCs. This could 
further explain the migration difference between the 
MSCs from the ovX and those from adult and younger 
rats, where the ovX rats were seen to perform much 
more poorly in the Boyden chamber. However, the cur-
rent study did not measure the effect of oestrogen on 
the migration of stem cells from young, ovX or senile 
rats.
The differentiation of MSCs to osteoblasts is a com-
plex process that involves the interaction of numerous 
hormones, autocrine and paracrine processes, and sys-
temic growth factors.26 We found that stem cell migra-
tion towards SDF-1 is reduced after osteogenic 
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Graph showing the mean percentage and uninfected rBMCs, osteogenic-differentiated rBMCs and CXCR4-infected rBMCs migration of infected differentiated 
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Flow cytometry to analyse the chemokine receptor type 4 (CXCR4) expression of rBMCs post osteogenesis. The arrow shows the positive shift of the CXCR4-
expressing osteoblasts (a) Positive Alizarin Red (b) and osteocalcin staining (c) expressed at day 21 of osteogenic-differentiated rBMCs. 
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induction even though the cells were over-expressed 
with CXCR4 prior to differentiation. The diminished 
migration of the differentiated MSCs may be a result of 
increased extra-cellular matrix deposition, and subse-
quently greater surface adherence. Matrix metallopro-
teinases (MMP) play a significant role in several 
differentiation events. MMPs are also involved in regu-
lating osteoblast proliferation and apoptosis.27,28 
However, it has been shown that MMPs inactivate 
SDF-1 and this may implicate the migration of osteo-
blasts.29 This could further imply that the SDF-1/CXCR4 
axis is no longer required once the osteogenic differen-
tiation pathway has been set in motion, as the migra-
tion of osteoblasts is no longer relevant once the stem 
cells have homed to the site of injury and started dif-
ferentiating into bone cells.30 Additionally, the role of 
an osteoblast is to secrete osteoid in an orientated man-
ner and migration of cells may impair this localised pro-
duction. liu et al30 found that when the cells were 
pre-treated with anti-SDF-1 and anti-CXCR4 antibody 
for six hours, expression of BMP-9-induced Runt-related 
transcription factor 2 (RuNX2) and osterix (oSX), 
which are markers of osteogenesis, was reduced signifi-
cantly, highlighting the importance of SDF-1/CXCR4 in 
initiating osteogenesis.30 However, although the 
CXCR4/SDF-1 axis may be involved in the induction of 
early stages of osteogenic differentiation, their levels 
were seen to diminish during osteogenesis.30,31
The importance of CXCR4 in improving bone loss in 
osteopaenic animals has been highlighted in previous 
studies. lien et al’s10 study looked at the migration of 
MSCs transfected with CXCR4 and Cbfa-1 in osteopaenic 
mice, and Cho et al’s11 study similarly looked at the 
migration of stem cells transfected with CXCR4 and 
RANK-Fc in osteopaenic mice. However, this study 
emphasises the differences in CXCR4 expression between 
MSCs from ovariectomised rats, adult and young rats, as 
well as their differences in migration in vitro, which were 
improved after CXCR4 transfection. MSCs from ovX rats 
have poor migration ability, and CXCR4 was observed to 
be the most effective in improving their migration com-
pared with MSCs from young rats. Moreover, we also 
looked at the migration of osteoblasts and showed that 
over-expressing differentiated rat MSCs with CXCR4 does 
not improve their migration.
The main limitation of this study is that it has been car-
ried out in vitro and this is associated with cells in mon-
olayer culture, with little surrounding extracellular matrix 
and other cell types. Therefore, this may influence the 
migration of MSCs. There may be other factors apart from 
CXCR4 that affect migration in vivo and these include inte-
grins, cadherins, and other adhesion factors. For cells to 
migrate they must disrupt the cell-to-cell contact and cell-
to-matrix contact and, for this, the cadherins and integrins 
contact must be disrupted through locally released 
enzyme. This has also not been investigated in this study. 
In a fracture situation, MSCs might migrate from the 
blood stream, bone marrow, muscle or periosteum. The 
periosteum is an important source of mesenchymal stem 
cells, but in this study we have only investigated stem 
cells derived from a bone marrow aspirate and it would 
be very interesting to measure the migration potential of 
MSCs derived from different sources.
This is a novel study because it shows that MSCs from 
osteopaenic rats have a poor migration capacity. This may 
be associated with the inability of osteoporotic patients to 
heal fractures. The reduced migration to SDF-1-producing 
cells may possibly indicate that there is a reduced stem 
cell number at the fracture site compared with that found 
in non-osteoporotic individuals, but further research in 
vivo needs to be done to validate the effect of CXCR4 on 
stem cell migration. Nevertheless, the maintained migra-
tion response upon upregulation of CXCR4 in rats illus-
trates the therapeutic potential of CXCR4-expressing 
MSCs in the treatment of osteoporotic fractures.
Supplementary material
Details of differentiation and characterisation of 
stem cells can be found alongside the online ver-
sion of this article at www.bjj.boneandjoint.org.uk
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